Laajam M A
Department of Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
East Afr Med J. 1990 Oct;67(10):732-6.
The effect of fasting during the holy month of Ramadan on the metabolic control of 39 patients with overweight and non-insulin-dependent diabetes (NIDD) was studied. There were 29 females and 10 males with a mean age of 51.5 +/- 1.65 years and body mass index of 31.5 +/- 0.98 kg/m2. All were treated with diet and oral hypoglycaemic agents (OHA). There was no change in body weight, fasting plasma glucose, glycosylated haemoglobin (HbA1), C-peptide and insulin blood levels at the end of fasting. Total blood cholesterol concentration rose significantly (p 0.05) but not triglycerides at the end of Ramadan. There were no acute metabolic complications (e.g. hypoglycaemia) in the present study. We conclude that fasting during Ramadan is generally safe in NIDD. However, patients should be advised to make use of this opportunity to combine the spiritual benefit with improvement in the metabolic control of the diabetes mainly through weight reduction.
研究了斋月禁食对39例超重及非胰岛素依赖型糖尿病(NIDD)患者代谢控制的影响。其中有29名女性和10名男性,平均年龄为51.5±1.65岁,体重指数为31.5±0.98kg/m²。所有患者均接受饮食及口服降糖药(OHA)治疗。禁食结束时,体重、空腹血糖、糖化血红蛋白(HbA1)、C肽及胰岛素血水平均无变化。斋月结束时,总血胆固醇浓度显著升高(p<0.05),但甘油三酯无变化。本研究中未出现急性代谢并发症(如低血糖)。我们得出结论,斋月期间禁食对NIDD患者总体上是安全的。然而,应建议患者利用这个机会,主要通过减轻体重,将精神益处与改善糖尿病代谢控制相结合。